ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES
Open Access
- 1 January 2017
- journal article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 13 (2) , 270-274
Abstract
The role of randomized controlled trials (RCTs) and observational studies in evaluation of the efficacy and safety of drugs in cardiology is discussed. The possibility of using the results of non-interventional studies in accepting the decision to choose the most effective and safe drug is presented in more detail.Keywords
This publication has 21 references indexed in Scilit:
- Poor medication adherence in clinical trials: consequences and solutionsNature Reviews Drug Discovery, 2017
- Methods for Measuring, Enhancing, and Accounting for Medication Adherence in Clinical TrialsClinical Pharmacology & Therapeutics, 2014
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Primary Medication Non-Adherence: Analysis of 195,930 Electronic PrescriptionsJournal of General Internal Medicine, 2010
- Clinical trials and registries in cardiovascular disease: competitive or complementary?European Heart Journal, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Defining an evidence-based cutpoint for medication adherence in heart failureAmerican Heart Journal, 2009
- Should Meta-Analyses of Interventions Include Observational Studies in Addition to Randomized Controlled Trials? A Critical Examination of Underlying PrinciplesAmerican Journal of Epidemiology, 2007
- How Much Compliance Is Enough?Pharmaceutical Research, 1996